Short answer: Yes—there are some long-term safety considerations with Ozempic (semaglutide). It’s generally well tolerated and has important benefits for many people, but certain risks need monitoring over time.
Key long-term concerns to be aware of
- Pancreatitis: Rare cases reported with GLP-1 receptor agonists. Seek medical attention for severe, persistent upper abdominal pain that may radiate to the back, with or without vomiting.
- Gallbladder disease: Increased risk of gallstones or cholecystitis has been observed with GLP-1 therapies; watch for right upper abdominal pain, fever, nausea, or vomiting.
- Thyroid concerns: In rodent studies there was a risk of thyroid C-cell tumors, and human data aren’t definitive. Ozempic carries a warning about medullary thyroid carcinoma (MTC) and MEN2. Do not use if you have a personal or family history of MTC or MEN2. Monitor for symptoms like a lump in the neck, trouble swallowing or hoarseness, and get thyroid evaluation if symptoms arise.
- Kidney function and dehydration: GI side effects (nausea, vomiting, diarrhea) can lead to dehydration, which can affect kidney function in some people. Staying hydrated and monitoring kidney function is common, especially in older adults.
- Gastrointestinal side effects: Nausea, vomiting, diarrhea, and abdominal pain are common when starting and may persist for weeks. For some, these limit long-term use.
- Hypoglycemia risk: Low risk on Ozempic alone, but the risk increases if combined with insulin or sulfonylureas. Dose adjustments may be needed.
- Weight and GI tolerance: Many people lose weight, which can be beneficial, but in some it’s not desired and GI intolerance may be limiting.
Potential long-term benefits
- Cardiovascular risk reduction has been shown in people with type 2 diabetes at high cardiovascular risk (lower risk of major adverse cardiovascular events in trials like SUSTAIN-6 for semaglutide).
- Durable A1C improvement and potential additional weight loss over time for many patients.
Monitoring and what to discuss with your clinician
- Regular check-ins to review blood sugar control (A1C), weight, blood pressure, and lipids.
- Discuss any history of pancreatitis, gallbladder disease, thyroid disease, or kidney problems.
- Report persistent GI symptoms, severe abdominal pain, unexplained weight loss, or symptoms suggestive of thyroid problems.
- If starting Ozempic and you have risk factors for thyroid disease or a family history of MTC or MEN2, make sure your clinician discusses risks and screening plans.
- Do not stop Ozempic suddenly without medical guidance; if side effects are troublesome, your doctor may adjust the dose or switch therapies.
Bottom line: Ozempic can be a helpful long-term therapy for many people with type 2 diabetes (and for weight management in other indications), but there are specific long-term safety considerations to monitor—especially pancreatobiliary health and thyroid concerns. If you want, tell me about your medical history, current dose, and any side effects you’ve had, and I can tailor this to your situation.